fluorodeoxyglucose f18 has been researched along with trelstar in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cartenì, G; Fusco, M; Pirozzi, A; Riccardi, F; Scagliarini, S | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and trelstar
Article | Year |
---|---|
Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Acinar Cell; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prednisone; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Triptorelin Pamoate; Vincristine | 2019 |